WeVote
Log In

Bill

Bill

HD 1157

An Act relative to pharmacy benefit managers

194th Legislature (2025-2026) Introduced by John Lawn

Massachusetts bill to regulate pharmacy benefit managers' pricing practices and increase transparency to lower prescription drug costs and protect independent pharmacies.

0
WeVote Research Nonpartisan
Bill Summary · HD 1157

Legislative bill overview

HD 1157 proposes regulatory reforms targeting pharmacy benefit managers (PBMs) in Massachusetts, likely including measures to increase transparency in drug pricing, reduce spread pricing (where PBMs profit from the difference between what they pay pharmacies and what they charge insurers), and strengthen oversight of PBM practices. The bill aims to address concerns about PBMs' market power and their role in driving up prescription drug costs for consumers and pharmacies.

Why is this important

PBMs control drug distribution for millions of Massachusetts residents through insurance plans, giving them significant influence over drug prices and pharmacy profitability. Reforms could reduce prescription drug costs for consumers, improve pharmacy financial viability (particularly for independent pharmacies), and increase price transparency in the healthcare supply chain.

Potential points of contention

  • Industry opposition: PBMs and large insurers may argue that restrictions on their business practices could increase administrative costs and ultimately raise premiums for consumers
  • Definition and enforcement challenges: Specific regulations on spread pricing and transparency requirements require clear definitions to be enforceable and may be technically complex
  • Unintended consequences: Reforms limiting PBM profits could affect their ability to negotiate drug rebates with manufacturers, potentially offsetting savings to consumers

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.